Background <p>Transcatheter edge-to-edge mitral valve repair (M-TEER) represents an effective treatment modality for high-grade mitral valve regurgitation. The right ventricle (RV) to pulmonary artery (PA) coupling ratio has been indicated as a marker of right ventricular dysfunction (RVD), but evidence among M-TEER patients remains inconsistent to date due to divergent definitions. We therefore aimed to shed light on the impact of RV-PA uncoupling on survival following M-TEER.</p> Methods <p>Data from all patients who underwent M-TEER and provided sufficient echocardiographic data were investigated. RV-PA uncoupling was defined as the ratio of tricuspid annular pulse systolic excursion (TAPSE) and to the Doppler echocardiographic-derived pulmonary artery systolic pressure (D-PASP) &lt; 0.37&#xa0;mm/mmHg.</p> <p>The difference in long-term survival between patients with and without RV-PA uncoupling were analyzed via the Kaplan-Meier method, and independent predictors of mortality were identified via uni- and multivariable Cox regression analyses.</p> Results <p>A total of 158 patients were eligible for analysis, and RV-PA uncoupling was present in 32.3% of the patients (51/158). Patients with RV-PA uncoupling presented significantly advanced congestive heart failure stages. While M-TEER was performed equally safely in patients with RV-PA uncoupling (odds ratio for procedural success: 0.95, 95% confidence interval [CI] 0.29–2.77, <i>p</i> = 0.9), their long-term survival three years after M-TEER was significantly worse (50.9% (26/51) vs. 61.7% (66/107), <i>p</i> = 0.01). In this regard, a TAPSE/D-PASP ratio &lt; 0.37&#xa0;mm/mmHg proved to be a more consistent discriminator of long-term survival than a TAPSE &lt; 18&#xa0;mm alone.</p> Conclusion <p>RV-PA uncoupling, defined as a TAPSE/D-PASP ratio of &lt; 0.37&#xa0;mm/mmHg, is a feasible and reproducible parameter, which also serves as a marker for advanced congestive heart failure and worse survival outcomes.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Prognostic value of the TAPSE/PASP-ratio in patients with severe mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair

  • Felix Ausbuettel,
  • Fares Kano,
  • Nikolaos Patsalis,
  • Christin Fichera,
  • Dimitar Divchev,
  • Carlo-Federico Fichera

摘要

Background

Transcatheter edge-to-edge mitral valve repair (M-TEER) represents an effective treatment modality for high-grade mitral valve regurgitation. The right ventricle (RV) to pulmonary artery (PA) coupling ratio has been indicated as a marker of right ventricular dysfunction (RVD), but evidence among M-TEER patients remains inconsistent to date due to divergent definitions. We therefore aimed to shed light on the impact of RV-PA uncoupling on survival following M-TEER.

Methods

Data from all patients who underwent M-TEER and provided sufficient echocardiographic data were investigated. RV-PA uncoupling was defined as the ratio of tricuspid annular pulse systolic excursion (TAPSE) and to the Doppler echocardiographic-derived pulmonary artery systolic pressure (D-PASP) < 0.37 mm/mmHg.

The difference in long-term survival between patients with and without RV-PA uncoupling were analyzed via the Kaplan-Meier method, and independent predictors of mortality were identified via uni- and multivariable Cox regression analyses.

Results

A total of 158 patients were eligible for analysis, and RV-PA uncoupling was present in 32.3% of the patients (51/158). Patients with RV-PA uncoupling presented significantly advanced congestive heart failure stages. While M-TEER was performed equally safely in patients with RV-PA uncoupling (odds ratio for procedural success: 0.95, 95% confidence interval [CI] 0.29–2.77, p = 0.9), their long-term survival three years after M-TEER was significantly worse (50.9% (26/51) vs. 61.7% (66/107), p = 0.01). In this regard, a TAPSE/D-PASP ratio < 0.37 mm/mmHg proved to be a more consistent discriminator of long-term survival than a TAPSE < 18 mm alone.

Conclusion

RV-PA uncoupling, defined as a TAPSE/D-PASP ratio of < 0.37 mm/mmHg, is a feasible and reproducible parameter, which also serves as a marker for advanced congestive heart failure and worse survival outcomes.